Friday, 21 Feb 2020

You are here

Panel Presentation: Psoriatic Arthritis

Drs. Eric Ruderman, Alexis Ogdie, Jessica Walsh, and Jose Scher discuss the giselkumab trials, where IL-23 inhibitors fit in practice, ixekizumab withdrawal, and more that presented at the 2019 ACR/ARP annual meeting in Atlanta.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Olga Petryna: Cardiovascular...

07 Nov 2017

Drs. Mark Vercel & Nisha Dsilva on...

13 Nov 2016

Dr. Jack Cush: RheumNow at ACR 2018

21 Oct 2018

The Week in Review - 11 March 2016

11 Mar 2016

RWCS 2017: Etanercept-induced...

21 Feb 2017

RheumNow Week in Review – 22 July 2016

22 Jul 2016

The RheumNow Week in Review – 24 March...

24 Mar 2017

Dr. Janet Pope: Cancer

07 Nov 2017

Daniel Lovell, MD: abatacept in JIA

11 Nov 2015

RheumNow Podcast – Can RA Be Prevented...

07 Dec 2018

RheumNow Live Preview with Dr. Eric...

24 May 2019

Arthritis with a Blastic Plasmacytoid...

17 Feb 2020